Simplex Trading
UNCY icon

Simplex Trading’s Unicycive Therapeutics UNCY Stock Holding History

Simplex Trading’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.3K Buy
+5,820
New +$38.1K ﹤0.01% 6143

Other funds holding UNCY

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's UNCY Position: Q1 2026 in Review

Simplex Trading opened a new position in Unicycive Therapeutics (UNCY) in Q1 2026: 5,820 shares worth $38.3K. The stake represents ﹤0.01% of the portfolio and ranks #6143 among its holdings.

51 funds tracked by Wall St. Rank hold UNCY as of Q1 2026.

  • Simplex Trading held 5,820 shares of Unicycive Therapeutics worth $38.3K as of Q1 2026.
  • Unicycive Therapeutics was a new Simplex Trading position in Q1 2026.
  • Unicycive Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6143 holding.
  • 51 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.